Ahead of the FDA’s June target action date for Sarepta’s Duchenne muscular dystrophy gene therapy, ICER Chief Medical Officer David Rind blasted the regulator’s accelerated pathway in a JAMA viewpoint ...
The agency has recently increased scrutiny of plastic syringes made in China because of safety concerns, including blocking imports from two Chinese manufacturers.
Law Offices of Howard G. Smith announces an investigation on behalf of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN) inv ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
This time around, Fierce Biotech kicked off its inaugural Best Biotech Name tournament, while over at Fierce Pharma Marketing, we held our biannual Drug Names tournament. The editors discuss what ...
[Related: Taro announces merger agreement with Sun Pharma] At the meetings, Taro shareholders will be asked to consider and vote on the approval, pursuant to Section 320 of the Companies Law ...
The US Food and Drug Administration (US FDA) has released a detailed report on six observations it reported following a recent inspection at Sun Pharmaceutical ... a Field Alert for Product ...
“Harmful reactions” from women in nine states led to alerts from the FDA and CDC this week about fake Botox, unlicensed medical facilities and unlicensed people giving the shots. Here’s what ...
“Harmful reactions” from women in nine states led to alerts from the FDA and CDC this week about fake Botox, unlicensed medical facilities and unlicensed people giving the shots. Here’s what ...
“Harmful reactions” from women in nine states led to alerts from the FDA and CDC this week about fake Botox, unlicensed medical facilities and unlicensed people giving the shots. Here’s what ...
“Harmful reactions” from women in nine states led to alerts from the FDA and CDC this week about fake Botox, unlicensed medical facilities and unlicensed people giving the shots. Here’s what ...